The US Food and Drug Administration has also started to recognize the potential of these drugs: in 2018, they designated certain psychedelic treatments with a “breakthrough therapy” status, which means that it has therapeutic potential. Several renowned medical schools and hospitals around the United States have also opened psychedelic medicine departments which have been entirely devoted to studying the impact of psilocybin and LSD.
Cannabis grower and edibles pioneer Maya Elisabeth makes the case that your sourdough starter is…
Berlin police are warning residents after receiving reports that suspected drug samples were being left…
Cannabis culture survived through decentralized human connection. Its future depends on whether the people building…
For years, the cannabis world has treated "the entourage effect" like settled science, a comforting…
After five years, two applications, six figures in expenses, and a maze of shifting rules,…
This article was originally published in 2023. From the hash and honey oil of the…